Neurocrine Biosciences Inc (NBIX) — Financial Flexibility Index
Neurocrine Biosciences Inc (NBIX) has a Financial Flexibility Index of 0.28x as of December 2025. Free cash flow of $390.80 Million (operating CF $388.40 Million minus capex $2.40 Million) represents 0% of total liabilities ($1.38 Billion). Also explore NBIX net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neurocrine Biosciences Inc Financial Flexibility Index (1996–2025)
Historical Financial Flexibility Index trend for Neurocrine Biosciences Inc across 30 annual periods. Check NBIX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Neurocrine Biosciences Inc (1996–2025)
Year-by-year free cash flow to debt coverage for Neurocrine Biosciences Inc. For the full company profile including market capitalisation, see NBIX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | $816.70 Million | $782.70 Million | $1.38 Billion | ▲ +5.6% |
| 2024 | 0.56x | $633.60 Million | $595.40 Million | $1.13 Billion | ▲ +36.8% |
| 2023 | 0.41x | $418.20 Million | $389.90 Million | $1.02 Billion | ▼ -23.8% |
| 2022 | 0.54x | $355.90 Million | $339.40 Million | $660.90 Million | ▲ +34.4% |
| 2021 | 0.40x | $279.90 Million | $256.50 Million | $698.50 Million | ▲ +1.9% |
| 2020 | 0.39x | $239.40 Million | $228.50 Million | $608.50 Million | ▲ +62.8% |
| 2019 | 0.24x | $161.70 Million | $147.00 Million | $669.10 Million | ▼ -1.9% |
| 2018 | 0.25x | $126.20 Million | $101.40 Million | $512.39 Million | ▲ +225.5% |
| 2017 | -0.20x | $-87.39 Million | $-94.33 Million | $445.45 Million | ▲ +90.3% |
| 2016 | -2.03x | $-102.07 Million | $-106.18 Million | $50.21 Million | ▼ -183.7% |
| 2015 | -0.72x | $-36.06 Million | $-38.00 Million | $50.33 Million | ▲ +46.0% |
| 2014 | -1.33x | $-45.53 Million | $-47.14 Million | $34.33 Million | ▼ -56.3% |
| 2013 | -0.85x | $-29.06 Million | $-29.61 Million | $34.27 Million | ▼ -2.8% |
| 2012 | -0.82x | $-34.32 Million | $-35.29 Million | $41.61 Million | ▼ -124295.3% |
| 2011 | 0.00x | $52.00K | $-698.00K | $78.29 Million | ▼ -99.8% |
| 2010 | 0.40x | $50.26 Million | $49.94 Million | $125.08 Million | ▲ +150.6% |
| 2009 | -0.79x | $-53.06 Million | $-53.09 Million | $66.86 Million | ▲ +11.3% |
| 2008 | -0.89x | $-72.84 Million | $-74.17 Million | $81.41 Million | ▼ -140.7% |
| 2007 | -0.37x | $-58.71 Million | $-59.33 Million | $157.96 Million | ▲ +71.0% |
| 2006 | -1.28x | $-96.22 Million | $-99.33 Million | $74.96 Million | ▼ -406.8% |
| 2005 | -0.25x | $-23.56 Million | $-30.79 Million | $93.02 Million | ▲ +32.2% |
| 2004 | -0.37x | $-46.84 Million | $-99.99 Million | $125.39 Million | ▼ -169.9% |
| 2003 | 0.53x | $87.57 Million | $37.13 Million | $163.84 Million | ▲ +130.5% |
| 2002 | -1.75x | $-74.06 Million | $-79.36 Million | $42.28 Million | ▼ -248.9% |
| 2001 | -0.50x | $-18.05 Million | $-21.86 Million | $35.96 Million | ▲ +29.5% |
| 2000 | -0.71x | $-16.20 Million | $-18.64 Million | $22.75 Million | ▼ -11.2% |
| 1999 | -0.64x | $-8.20 Million | $-10.30 Million | $12.80 Million | ▲ +22.2% |
| 1998 | -0.82x | $-7.00 Million | $-10.70 Million | $8.50 Million | ▼ -141.2% |
| 1997 | 2.00x | $17.40 Million | $11.00 Million | $8.70 Million | ▲ +25.3% |
| 1996 | 1.60x | $8.30 Million | $6.70 Million | $5.20 Million | — |